Skip to content

Quarantine Notice – Sodium Chloride ampoules

The PHN is informing primary care providers that on 24/11/2023, the Public Health and Surveillance Branch in the Office of Health Protection of the Department of Health and Aged Care has issued a quarantine notice for the following product:

InterPharma Sodium Chloride 0.9% 10ml or 30ml ampoules.

The sponsor of the product will contact affected customers.

These products should be removed from use immediately and placed in quarantine until further notice.

The quarantine notice was released after several reported cases of Ralstonia pickettii in multiple jurisdictions, a pathogen with nosocomial significance.

For further questions, download the quarantine notice and contact details.

Explore more news like this:

More about:

HNECC PHN Announcement Pharmacy

For audiences:

General Practitioner Health Professionals Pharmacist

Keep up to date with the latest.

Subscribe to our mailing list to get all the latest news updates delivered to your inbox.

Related News

June 30 2023

Diversity Inclusion and Belonging a Priority for the PHN

In 2022, the PHN developed its 2022-2025 Diversity, Inclusion and Belonging Strategy. The strategy is critical to delivering the PHN’s community, workforce and cultural objectives and aligns to the PHN’s strategic purpose of “keeping people well in our communities through innovation, performance, collaboration and local engagement.”

Learn more about Diversity Inclusion and Belonging a Priority for the PHN